Fischer U - Search Results

1

Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.

Loges S, Butzal M, Otten J, Schweizer M, Fischer U, Bokemeyer C, Hossfeld DK, Schuch G, Fiedler W. Loges S, et al. Among authors: fischer u. Biochem Biophys Res Commun. 2007 Jun 15;357(4):1016-20. doi: 10.1016/j.bbrc.2007.04.060. Epub 2007 Apr 19. Biochem Biophys Res Commun. 2007. PMID: 17466276

2

Identification of the adult human hemangioblast.

Loges S, Fehse B, Brockmann MA, Lamszus K, Butzal M, Guckenbiehl M, Schuch G, Ergün S, Fischer U, Zander AR, Hossfeld DK, Fiedler W, Gehling UM. Loges S, et al. Among authors: fischer u. Stem Cells Dev. 2004 Jun;13(3):229-42. doi: 10.1089/154732804323099163. Stem Cells Dev. 2004. PMID: 15186719

3

Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.

Butzal M, Loges S, Schweizer M, Fischer U, Gehling UM, Hossfeld DK, Fiedler W. Butzal M, et al. Among authors: fischer u. Exp Cell Res. 2004 Oct 15;300(1):65-71. doi: 10.1016/j.yexcr.2004.07.002. Exp Cell Res. 2004. PMID: 15383315

4

Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.

Loges S, Heil G, Bruweleit M, Schoder V, Butzal M, Fischer U, Gehling UM, Schuch G, Hossfeld DK, Fiedler W. Loges S, et al. Among authors: fischer u. J Clin Oncol. 2005 Feb 20;23(6):1109-17. doi: 10.1200/JCO.2005.05.058. J Clin Oncol. 2005. PMID: 15718307

5

Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416.

Loges S, Tinnefeld H, Metzner A, Jücker M, Butzal M, Bruweleit M, Fischer U, Draab E, Schuch G, O'-Farrel AM, Hossfeld DK, Bokemeyer C, Fiedler W. Loges S, et al. Among authors: fischer u. Leuk Lymphoma. 2006 Dec;47(12):2601-9. doi: 10.1080/10428190600948253. Leuk Lymphoma. 2006. PMID: 17169805 Clinical Trial.

6

Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.

Dietz J, Spengler U, Müllhaupt B, Schulze Zur Wiesch J, Piecha F, Mauss S, Seegers B, Hinrichsen H, Antoni C, Wietzke-Braun P, Peiffer KH, Berger A, Matschenz K, Buggisch P, Backhus J, Zizer E, Boettler T, Neumann-Haefelin C, Semela D, Stauber R, Berg T, Berg C, Zeuzem S, Vermehren J, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Clin Gastroenterol Hepatol. 2021 Jan;19(1):195-198.e2. doi: 10.1016/j.cgh.2019.10.051. Epub 2019 Nov 6. Clin Gastroenterol Hepatol. 2021. PMID: 31706062 Free article.

7

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.

Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158

8

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.

Dietz J, Susser S, Vermehren J, Peiffer KH, Grammatikos G, Berger A, Ferenci P, Buti M, Müllhaupt B, Hunyady B, Hinrichsen H, Mauss S, Petersen J, Buggisch P, Felten G, Hüppe D, Knecht G, Lutz T, Schott E, Berg C, Spengler U, von Hahn T, Berg T, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Gastroenterology. 2018 Mar;154(4):976-988.e4. doi: 10.1053/j.gastro.2017.11.007. Epub 2017 Nov 13. Gastroenterology. 2018. PMID: 29146520

9

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.

Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.

10

International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis.

Brakel BA, Rebchuk AD, Ospel J, Chen Y, Heran MK, Goyal M, Hill MD, Miao Z, Huo X, Sacco S, Yaghi S, Mai TD, Thomalla G, Boulouis G, Yamagami H, Hu W, Nagel S, Puetz V, Kristoffersen ES, Demeestere J, Qiu Z, Abdalkader M, Al Kasab S, Siegler JE, Strbian D, Fischer U, Coutinho JM, van de Munckhof A, Aguiar de Sousa D, Campbell B, Raymond J, Ji X, Saposnik G, Nguyen TN, Field TS. Brakel BA, et al. Among authors: fischer u. Int J Stroke. 2024 Nov 21:17474930241304206. doi: 10.1177/17474930241304206. Online ahead of print. Int J Stroke. 2024. PMID: 39569543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,489 results

Search Page

Filters